Navigation Links
Antares Pharma Announces Positive Results from Application Site,Study for Anturol

s, Minnesota and Basel, Switzerland.

Safe Harbor Statement

In addition to historical facts or statements or current conditions, this press release contains forward-looking statements within the meaning of the "Safe Harbor" provisions of The Private Securities Litigation Reform Act of 1995, including statements regarding the positive results. Forward-looking statements provide Antares' current expectation or forecasts of future events. Antares' results could differ materially from those reflected in these forward-looking statements due to decisions of regulatory authorities, Antares' ability to execute on its development plans and general financial, economic, regulatory and political conditions affecting the pharmaceutical industry generally. For a discussion of these and other risks and uncertainties that may effect the forward-looking statements, please see the risk factors in Antares' 10Q's, 10K's and other filings made with the Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Antares undertakes no obligation to update publicly any forward-looking statement.

Contact

Antares Pharma, Inc.
Stephanie M. Baldwin, 609-359-3020
sbaldwin@antarespharma.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:10/8/2008)...mab Program to be Discontinued and Headcount to be... its Portfolio Review; Zanolimumab Program to be ...r of Employees, COP...b A/S (OMX: GEN),announced today that it is discon... In addition, as a result of a portfolio review an...
(Date:10/8/2008)...gs Confirm Potency of Poly-ICR as Vaccine Adjuvant...nta Biopharmaceuticals,Corporation (TSX: NVN) toda... using its proprietary Toll-like Receptor 3 agonis...Vaccine Congress 2008 in Lyon, France.,Study resul...juvant,targeting the Toll-like Receptor 3 (TLR3) p...
(Date:10/7/2008)...ct. 7 /- Prometheus Laboratories Inc....ced findings from its,development of PROMETHEUS(R)... irritable bowel syndrome (IBS). The findings sugg...rticular biomarkers in blood samples,between IBS a...iomarkers,combined with a proprietary algorithm, ...
(Date:10/7/2008)...s, Oct. 7 /- The Texas Cardiac Arrhyt...r has been selected as one of,only a few sites in ...cal,trial for a new device to treat persistent atr..., training and research center specializing in hea...David,s Medical Center and,Texas Cardiovascular Co...
Breaking Medicine Technology:Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Park Dental Announces Separation From Its Administrative Service Provider 13335 1Park Dental Announces Separation From Its Administrative Service Provider 13335 2Park Dental Announces Separation From Its Administrative Service Provider 13335 3Highlands Acquisition Corp Receives Non Compliance Letter From Amex 13334 1Highlands Acquisition Corp Receives Non Compliance Letter From Amex 13334 2Pump It Up and Autism Society of America Launch Bounce for Autism 13331 1Pump It Up and Autism Society of America Launch Bounce for Autism 13331 2Pump It Up and Autism Society of America Launch Bounce for Autism 13331 3MSU research indicates testosterone could guard against eating disorders 13329 1MSU research indicates testosterone could guard against eating disorders 13329 2
...the CDC that none of its influenza vaccine (Fluvir...ted States for the current influenza season. In th...e anticipated American vaccine supply, medical off...gly alarmed about the scarcity of vaccine and the ...e seen if virulent new strains of flu or an abnorm...
...f rapid, easy-to-use diagnostic tests, many assays...ace to help clinicians assess dosage appropriatene...ence of drugs of abuse. Some of these products req...s are suitable for point of care use by medical pr..., Therapeutic drug monitoring measures the serum ...
Other Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4
(Date:10/10/2008)...t. 10 /PRNewswire/ -- A nationally recognized facu...ies for patients with breast,cancer in the multime...tegies: From Biomarkers to Treatment Selection" du...is challenging for practicing oncologists and othe...ate on the latest patient care,advances. This accr...
(Date:10/9/2008)...ACH, Fla., Oct. 9 /PRNewswire/ -- This may sound l...reality. Internationally,acclaimed anti-aging Doct...licensed to provide TA-65 to the public through hi...ida., This is a revolutionary technology that is ...our DNA. They are located at the ends of all the,c...
(Date:10/9/2008)...y Rewards and Educational Opportunities for Those ...PHILADELPHIA, Oct. 9 /PRNewswire/ -- In recognitio...Blue Cross (IBC) honors its more than,590 customer... with fun,healthy activities this week and celebr...., Fielding more than 4 million inquiries a year,...
(Date:10/9/2008)...s., Oct. 9 /PRNewswire/ -- Nature,s Way Holding Co...hwabe Pharmaceuticals, a leading,worldwide produce...,agreement to acquire all outstanding shares of En...he controlling shareholder of Enzymatic Therapy. T...vering their signatures and,provides for customary...
Breaking Medicine News(10 mins):Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 3Health News:Independence Blue Cross Celebrates Customer Service Week 2Health News:Schwabe, World Leader in Herbal Manufacturing Will Acquire Enzymatic Therapy Through Nature's Way Holding, Inc. 2Health News:Schwabe, World Leader in Herbal Manufacturing Will Acquire Enzymatic Therapy Through Nature's Way Holding, Inc. 3
... sex hormone levels during women’s menstrual cycle...d circuitry, an imaging study at the National Inst...e National Institutes of Health (NIH), has reveale...their circuitry was more active if they were in a ...
...erall cancer death rate in African Americans has c...te was 35 percent higher in African American men a...han in white men and women in the most recent time...ity among men has narrowed over the past 10 years ...
...outh heal more slowly in women and older adults, a...o reveals.// "While wounds to the skin heal more ...the opposite is true for healing of wounds inside ...rucha, head of periodontics at the UIC College of ...
...llion men in the United States over age 20 are aff...udy by researchers from the Johns Hopkins Bloomber...ile dysfunction was strongly linked with age, card...of physical activity. The findings also indicate...
Other Medicine News:Health News:NIMH Studies Woman’s Hormonal Cycl 2Health News:Cancer Death Rates High in African-Americans 2Health News:Oral Wounds Heal Slower in Women, Older Adults 2Health News:More Than 18 Million US Men Affected by ED 2
...medication, food, exercise, stress . . . Theyre al...health. Unfortunately, its difficult, and often ov...tion on a daily basis. Its even more difficult to ...formation to a care provider quickly so healthcare...
...es requires making decisions about insulin dosages... These decisions are guided by data from blood glu...the patterns that can be seen by you and your Heal...ganized and graphical formats. The FreeStyle CoPil...
...t Solid-State Three-Color Photocoagulator.,Retin...purchase over 3,000 Lumenis multi-color photocoagu...ractice, the Novus Varia integrates green, yellow,... single, compact system that supports your treatme...
...pe 14, 14A and 14C have been approved. The three r...modate the variations in the size of the individua... rings are designed to stabilize the capsule and h...e panel of U.S. ophthalmologists. For implatation...
Medicine Products: